DNMT1 and cancer: Interestingly, treatment of these OXPHOS inhibitors (Gboxin, Oligomycin A, and Berberine) decreases DNMT1 expression in OXPHOS inhibition‐sensitive cancer cells (Figure 4H–J), implying a reciprocal regulation between mitochondrial metabolism and epigenetic regulation.